Gen Incode

Developer of precison medicines by combining genetic and clinical data for cardiac disease monitoring

placeManchester, England, United Kingdom calendar_todayFounded 2018 groups26 employees language genincode.com

Registered entities

Social engagement

Social engagement: 6.5K social following, 5 posts in the last 12 months — around the industry typical range.

Investor mix

6 investors on record; lead investors include Maven Capital Partners, Downing.

Investor typeCountShare
Venture capital117%
Private equity233%
Other / undisclosed350%

Recent activity

17 Jun 2026
Event
ACC/AHA Lipid Updates and Case Studies in Polygenic Risk Scoring
11 Jun 2026
Event
National Lipid Association Scientific Sessions 2026
10 Jun 2026
Event
ACC/AHA Lipid updates and case studies in Polygenic Risk Scores (PRS)
Coming soon